Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
March 06 2008 - 2:33PM
PR Newswire (US)
IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Cardiogenesis
Corporation (Pink Sheets: CGCP), announced that the company will
release its earnings for the fourth quarter and full year ended
December 31, 2007 prior to market open on Tuesday, March 25, 2008.
The company also said that President Richard P. Lanigan and Senior
Vice President and Chief Financial Officer William R. Abbott will
host an investor conference call that day at 12:00 p.m. Eastern
time (9:00 a.m. Pacific time) to review the company's financial
results and business outlook. The call is open to all interested
investors through a live audio web broadcast via the Internet at
http://www.cardiogenesis.com/ and will also be available by dialing
(800) 901-5241. The participant passcode is 15597145. The call will
be archived on the company's web site and will be available for
playback for seven days beginning shortly after the live webcast.
About Cardiogenesis Corporation Cardiogenesis is a medical device
company specializing in the treatment of cardiovascular disease and
is a leader in devices that stimulate cardiac angiogenesis. The
company's market leading Holmium: YAG laser system and disposable
fiber-optic accessories are used to perform a FDA-cleared surgical
procedure known as Transmyocardial Revascularization (TMR) to treat
patients suffering from angina. Surgical products and accessories
for the Cardiogenesis TMR procedure, which are marketed in the U.S.
and around the world, have been shown to reduce angina and improve
the quality of life in patients with coronary artery disease.
Surgical products and accessories for the company's minimally
invasive Percutaneous Myocardial Channeling (PMC) procedure are
currently being marketed in Europe and other international markets.
For more information on the company and its products, please visit
the Cardiogenesis company website at http://www.cardiogenesis.com/
or the direct to patient website at http://www.heartofnewlife.com/.
Cardiogenesis Corporation, +1-949-420-1800
http://www.cardiogenesis.com/ DATASOURCE: Cardiogenesis Corporation
CONTACT: William R. Abbott, Senior Vice President and Chief
Financial Officer of Cardiogenesis Corporation, +1-949-420-1800 Web
site: http://www.cardiogenesis.com/ http://www.heartofnewlife.com/
Copyright